Trending Stock under Radar: Argos Therapeutics (ARGS)

Shares are clocking price at $0.16 with change of 5.53%. The mean target projections are based on 1 opinions. In contrast to the year ago quarter EPS was at -1.53. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company.

Valuation Ratios of Argos Therapeutics, Inc. The stock now has Weekly Volatility of 12.43% and Monthly Volatility of 8.66%. The latest exchange of 8.56 Million shares is above its average trading activity of 10.24 Million shares.

Argos Therapeutics, Inc. (ARGS) now the company's industry has 31.17 P/E and the sector P/E is 32.99. The average true range (ATR) is a measure of volatility introduced by Welles Wilder. The average analysts gave this company a mean recommendation of 2.80. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Several studies suggest that positive earnings surprises not only lead to an immediate hike in a stock's price, but also to a gradual increase over time.

Argos Therapeutics, Inc. (NASDAQ:ARGS) reported its EPS in the last quarter as $-0.19/Share beating the analyst estimate of $-0.26/Share by a difference of $0.07. For the current year the company's revenue estimates are $380 Million compared to low analyst estimates of $380 Million and high estimates of $380 Million according to the prediction of 1 analysts.

1 number of analysts have estimated the sales of the company for the quarter ending Mar 30, 2017- Mar 31, 2017, analysts estimated mean sale target of 0.38 million while high and low sale targets are estimated at 0.38 million and 0.38 million respectively.

Currently Argos Therapeutics (NASDAQ:ARGS)'s shares owned by insiders are 3.8%, whereas shares owned by institutional owners are 9.4%.

The company's stock is now moving with a -ve distance from the 200 day SMA of approximately -82.31%, and has a solid year to date (YTD) performance of -96.94% which means that the stock is constantly adding to its value from the previous fiscal year end price.

Argos Therapeutics, Inc. (NASDAQ:ARGS) gross margin percentage stands at 0% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. Its book value per share for the most recent quarter is $-0.5 while its price to book ratio for the same period is 0, as for as the company's cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The stock touched 52-week High of $5.68 on 01/09/17 and 52-week Low of $0.13 on 11/02/17.

Tesla, Inc. (NASDAQ:TSLA), stock is trading $389.61 above the 52-week high and has displayed a high EPS growth of -13.10% in last 5 years.

Like this


09 November 2017
Tanger Factory Outlet Centers (NYSE:SKT) Has Increase in Shorts
The average investment rating for SKT on a scale of 1 to 5 (1 being a strong sell and 5 being a strong buy) is a 3.13 or a Hold. FMR LLC acquired a new stake in Tanger Factory Outlet Centers during the second quarter valued at approximately $30,625,000.

09 November 2017
April the giraffe may be pregnant AGAIN — GMA reveal
The owner of Animal Adventure Park in NY said on Good Morning America that he "can't confirm nor deny" the possibility of April being pregnant again.

09 November 2017
Merck & Company, Inc. (MRK) Shares Bought by Alpine Woods Capital Investors LLC
Balyasny Asset Limited Co invested 0.05% in 3M Co (NYSE:MMM). (NYSE:MRK) earned "Hold" rating by Jefferies on Tuesday, October 31. Duquesne Family Office Limited Liability Corporation holds 755,500 shares. 23,573 were reported by Weaver C Barksdale Assocs.

09 November 2017
Unusual Activity Sighted in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Shares
For shareholders, given the total diluted outstanding shares of 350.1 million, this means overall earnings per share of -0.11. The stock of Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) earned "Buy" rating by Cantor Fitzgerald on Tuesday, August 29.

09 November 2017
Unbiased Equity Research: Comcast Corporation (CMCSA), GGP Inc. (GGP)
It dropped, as 68 investors sold CMCSA shares while 503 reduced holdings. 110 funds opened positions while 468 raised stakes. Gardner Russo & Gardner Llc increased Vulcan Materials (NYSE:VMC) stake by 4,035 shares to 8,985 valued at $1.14M in 2017Q2.

09 November 2017
Analyzing the Financial Health of Schlumberger Limited (NYSE:SLB)
On a one to five ratings scale where 1.0 indicates a Strong Buy, 2.0 indicates a Buy, 3.0 a Hold, 4.0 a Sell and 5.0 a Stong Sell. With 2.13 million avg volume, 1 days are for Gevo Incorporated (NASDAQ:GEVO)'s short sellers to cover GEVO's short positions.

09 November 2017
Trump's Voter Fraud Commission Is Being Sued by One of Its Commissioners
According to the press release, Dunlap's suit is based on the 1999 Washington, D.C. federal Circuit Court decision in Cummock v. The panel was rattled last month by the arrest of a staff member on charges of possessing child pornography.

09 November 2017
Look out for Bangladeshis in Paradise Papers
The CPI expressed its disappointment with the probe and said that "even after 18 months no progress has been made". Its predecessor, the Panama Papers, allegedly revealed the names of some Bangladeshi businessmen and politicians.

09 November 2017
State Treasurer State of Michigan Sells 5100 Shares of Lennar Corporation (LEN)
The company reported $1.01 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.89 by $0.12. The total amount of shares outstanding is 232.54 million, giving the company a market capitalization of about 13.13 billion.

09 November 2017
'Jurassic World' Scribe Derek Connolly to Write 'Metal Gear Solid' Film
Since then, the series has gone on to spawn numerous sequels, off-shoots and prequels across various consoles and the home computer.